130 related articles for article (PubMed ID: 17914480)
1. Photodynamic therapy for cutaneous leishmaniasis: the effectiveness of topical phenothiaziniums in parasite eradication and Th1 immune response stimulation.
Akilov OE; Kosaka S; O'Riordan K; Hasan T
Photochem Photobiol Sci; 2007 Oct; 6(10):1067-75. PubMed ID: 17914480
[TBL] [Abstract][Full Text] [Related]
2. Optimization of topical photodynamic therapy with 3,7-bis(di-n-butylamino)phenothiazin-5-ium bromide for cutaneous leishmaniasis.
Akilov OE; Yousaf W; Lukjan SX; Verma S; Hasan T
Lasers Surg Med; 2009 Jul; 41(5):358-65. PubMed ID: 19533767
[TBL] [Abstract][Full Text] [Related]
3. Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells.
Akilov OE; Kosaka S; O'Riordan K; Hasan T
Exp Dermatol; 2007 Aug; 16(8):651-60. PubMed ID: 17620092
[TBL] [Abstract][Full Text] [Related]
4. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection.
O'Riordan K; Akilov OE; Chang SK; Foley JW; Hasan T
Photochem Photobiol Sci; 2007 Oct; 6(10):1117-23. PubMed ID: 17914486
[TBL] [Abstract][Full Text] [Related]
5. Phototoxicity, redox behavior, and pharmacokinetics of benzophenoxazine analogues in EMT-6 murine sarcoma cells.
Cincotta L; Foley JW; Cincotta AH
Cancer Res; 1993 Jun; 53(11):2571-80. PubMed ID: 8495421
[TBL] [Abstract][Full Text] [Related]
6. Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP.
Latorre-Esteves E; Akilov OE; Rai P; Beverley SM; Hasan T
J Biophotonics; 2010 Jun; 3(5-6):328-35. PubMed ID: 20376860
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
Asilian A; Davami M
Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497
[TBL] [Abstract][Full Text] [Related]
8. Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis.
Eissa MM; Amer EI; El Sawy SM
Exp Parasitol; 2011 Aug; 128(4):382-90. PubMed ID: 21620834
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy using methylene blue to treat cutaneous leishmaniasis.
Song D; Lindoso JA; Oyafuso LK; Kanashiro EH; Cardoso JL; Uchoa AF; Tardivo JP; Baptista MS
Photomed Laser Surg; 2011 Oct; 29(10):711-5. PubMed ID: 21671755
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Macrophage Activation Markers in an Experimental Model of Cutaneous Leishmaniasis Treated with Photodynamic Therapy Mediated by 5-Aminolevulinic Acid.
Silva MLF; Alves PM; Souza DM; Silva MV; Dos Santos JP; Paulino TP; Rodrigues DB; Rodrigues V
Photobiomodul Photomed Laser Surg; 2019 May; 37(5):298-304. PubMed ID: 31084559
[No Abstract] [Full Text] [Related]
11. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
Garnier T; Mäntylä A; Järvinen T; Lawrence J; Brown M; Croft S
J Antimicrob Chemother; 2007 Oct; 60(4):802-10. PubMed ID: 17715126
[TBL] [Abstract][Full Text] [Related]
12. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
[TBL] [Abstract][Full Text] [Related]
13. In vivo activity of perifosine against Leishmania amazonensis.
Cabrera-Serra MG; Valladares B; Piñero JE
Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro control of Leishmania mexicana due to garlic-induced NO production.
Gamboa-León MR; Aranda-González I; Mut-Martín M; García-Miss MR; Dumonteil E
Scand J Immunol; 2007 Nov; 66(5):508-14. PubMed ID: 17953527
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy of systemic miltefosine associated with photodynamic therapy with liposomal chloroaluminium phthalocyanine in the treatment of cutaneous leishmaniasis caused by Leishmania (L.) amazonensis in C57BL/6 mice.
Ribeiro JBP; Miranda-Vilela AL; Graziani D; Gomes MRA; Amorim AAS; Garcia RD; de Souza Filho J; Tedesco AC; Primo FL; Moreira JR; Lima AV; Sampaio RNR
Photodiagnosis Photodyn Ther; 2016 Mar; 13():282-290. PubMed ID: 26306406
[TBL] [Abstract][Full Text] [Related]
16. The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites.
Akilov OE; Kosaka S; O'Riordan K; Song X; Sherwood M; Flotte TJ; Foley JW; Hasan T
Chem Biol; 2006 Aug; 13(8):839-47. PubMed ID: 16931333
[TBL] [Abstract][Full Text] [Related]
17. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
18. Study of the efficacy of N-methyl glucamine antimoniate (Sb
Ribeiro JBP; Miranda-Vilela AL; Amorim AAS; Garcia RD; Moreira JR; Gomes CM; Takano GHS; de Oliveira GMF; Lima AV; da Silva ICR; Sampaio RNR
Photodiagnosis Photodyn Ther; 2019 Jun; 26():261-269. PubMed ID: 30951865
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous leishmaniasis responds to daylight-activated photodynamic therapy: proof of concept for a novel self-administered therapeutic modality.
Enk CD; Nasereddin A; Alper R; Dan-Goor M; Jaffe CL; Wulf HC
Br J Dermatol; 2015; 172(5):1364-70. PubMed ID: 25363817
[TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis.
Garnier T; Brown MB; Lawrence MJ; Croft SL
J Pharm Pharmacol; 2006 Aug; 58(8):1043-54. PubMed ID: 16872550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
